The Republican Party's strategy to attack the Affordable Care Act's employer mandate by redefining a full-time employee as someone who works 40 hours a week instead of 30 hours could increase dependence on government-provided health insurance.
In looking to chip away at President Obama's healthcare program, the Republican Party's strategy to redefine a full-time employee as someone who works 40 hours a week instead of 30 hours could increase dependence on government-provided health insurance.
The move to change the defined work week for full-time employees is aimed at the Affordable Care Act's employer mandate, which requires companies with at least 50 full-time employees—defined as people working at least 30 hours or more a week in the law—provide comprehensive and affordable health insurance to 95% of full-time workers or face penalties.
The Congressional Budget Office found that changing the mandate to define full-time employees as people at least 40 hours a week would mean 1 million people get dropped from their employer-sponsored insurance. As a result, between 500,000 and 1 million people would turn to options such as Medicaid, the Children's Health Insurance Program, and the ACA insurance exchanges. The move would increase the national deficit by $45.7 billion over a decade.
Read more at The Washington Post's Wonkblog: http://wapo.st/1zTKKDu
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More